ISSN: 2581-5407 Open Access Global Journal of Cancer Therapy Clinical Group

Global Journal of Cancer Therapy

    Introduction

    • Volume/IssueClick here
    • Review ProcessDouble Blind
      • Publication lead time3 - 4 weeks
      • Indexing statusYes; Purview
      • Manuscript Processing ChargesClick here
      • Submission ChargesNo
      • Waiver policy for APCYes
      • Language of Full TextEnglish
      • Full-text formats availablePDF, HTML
    • Show +
    • Permanent article identifierDOI (Digital Object Identifier)We provide DOI to all published papers. It'll facilitate for higher citation and classification.
      Peertechz Publisher ID: 10.17352
    • Type of LicenseCreative Commons
      • Open AccessYes; Policy
      • Does the author retain unrestricted copyright?Yes
      • Does the author retain publishing rights?Yes
    • Show +

    Editor-in-Chief

    M.Waheed Roomi

    M.Waheed Roomi
    Dr. Rath Research Institute
    1260 Memorex Drive, Santa Clara, USA
    Email: w.roomi@drrath.com
    Tel: (408)730-4481
    Fax: (408) 588-7174

    More Info.

    Tsuyoshi Shirakawa

    Tsuyoshi Shirakawa
    Kyushu University, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan
    Email: t-w-r@intmed1.med.kyushu-u.ac.jp
    Tel: +81-92-661-5395
    Fax: +81-955-70-1511

    More Info.


    Welcome from the desk of

    Dr. Tsuyoshi Shirakawa, MD., Executive Editor

    Welcome to our website! I am very happy for your visit.

    Global Journal of Cancer Therapy reports both clinical and experimental results related to cancer, and is using online review and Editorial Manager System for quality review process. The Journal invites all type of clinical and medical case reports, case studies, basic researches, clinical images, pharmacology and nursing, as it were, total oncology. The goal of us is to keep a record of the state-of-the-art research or case report and to promote study, research and improvement within its various specialties, then to develop total oncology.

    We believe your expertise knowledge will help in the growth of the journal and as well help many budding research scientists all around the world. Your article will be a key insight into real medical cases that are essential for physicians, and may ultimately help to improve patient outcomes.

    Editorial Board

    Jinbo Gao
    Department of Gastrointestinal Surgery
    Huazhong University of Science and Technology
    China
    gaojinbo@163.com
    GJCT

    Research Interest:  Gastric Cancer; Colon Cancer; Rectal Cancer; Interferon Regulatory Factor-1 (IRF-1); Chemotherapy; Drug Resistance; Telomerase

    More Info.
    Letizia Polito
    Assistant Professor
    Department of Experimental
    University of Bologna
    Italy
    letizia.polito@unibo.it
    GJCT

    Research Interest: The Scientific Activity Is Focused On Two Main Topics Concerning The Study Of Plant Toxins Known As Ribosome-Inactivating Proteins (Rips), And The Design And Testing In Vitro And In Vivo Of Immunotoxins For The Experimental Therapy Of Tumors And For The Immunosuppression.


    More Info.
    George F Samelis
    Medical Oncologist
    President of the Hellenic and International Society of Molecular
    National and Kapodistrian University of Athens
    Greece
    oncologydept.samelis@hippocratio.gr
    GJCT

    Research Interest: Lung-Pancreatic-Prostate-Cancers, Molecular Targeted Therapies


    More Info.
    Yan Baglo
    Research Fellow
    Fischell Department of Bioengineering
    University of Maryland
    USA
    ybaglo@umd.edu
    GJCT

    Research Interest: Cancer treatment regimens, photodynamic therapy, nanotechnology-enabled drug delivery.

    More Info.
    Shinq-Jen Wu
    Da-Yeh University
    Taiwan
    jen@mail.dyu.edu.tw
    GJCT

    Research Interest: Shinq-Jen Wu, Da-Yeh University, Chang-Hwa, Taiwan


    More Info.
    Kailash Chadha
    Department of Molecular and Cellular Biology
    Roswell Park Cancer Institute
    USA
    Kailash.Chadha@RoswellPark.org
    GJCT

    Research Interest: The Physiological Role Of PSA In Prostate Tissue Microenvironment, In Prostate Tumor Growth And Progression, And In Prostate Cancer Metastasis Is Not Known. Attenuation Of PSA Levels With Age, Disease Progression, Or During Androgen Deprivation Therapy, However, Removes This Important Regulator Of Angiogenesis, And By Extension Results In Tumor Progression. Re-Introduction Of Human PSA Into The Prostate Tissue Microenvironment May Suppress Tumor Angiogenesis Through Either The Inhibition Of Expression Of Pro-Angiogenic Genes Or Induction Of Expression Of Anti-Angiogenic Genes, Or Via Inhibition Of Signaling Mechanisms Associated With Angiogenesis That Are Independent Of Gene Transcription. Validation Of An Anti-Angiogenic Effect Of PSA On The Human Tissue Vasculature In A Pre-Clinical Model Of Primary Xenografts Of Human Prostate And Prostate Cancer Tissue Will Provide Compelling Evidence That PSA Has Therapeutic Potential Against Prostate Cancer.



    More Info.
    Raj Kumar Koiri
    Assistant Professor
    Department of Zoology
    Dr. Hari Singh Gour Central University
    India
    rkkoiri@dhsgsu.ac.in
    GJCT

    Research Interest: To study the metabolic adaptation for survival occurring in the cancer cells

    More Info.
    Zbigniew Antosz
    Department of Pathology
    Regional Specialistic Hospital
    Poland
    antosz@mp.pl
    GJCT

    Research Interest: Histopathology, Anatomical pathology, Experimental oncology


    More Info.
    Wei Du
    Hematology and Cancer Biology
    Cincinnati Childrens Hospital Medical Center
    USA
    Wei.Du@cchmc.org
    GJCT

    Research Interest: Stem Cell Biology And Pathophysiology Of Bone Marrow Failure And Leukemia; Identifying And Targeting The Alternative Oxidative DNA-Damage Response Pathways Required For Cancer Progression; The Role Of A Major Proliferating Protein, Nucleophosmin (NPM) In Cancer Development


    More Info.
    Tsuyoshi Shirakawa
    Department of Oncology
    Miyazaki University Hospital
    Japan
    twriver1979@gmail.com
    GJCT

    Research Interest: Medical Oncology (Mainly Gastrointestinal Cancer), Cancer Stem Cell, Palliative Medicine,Multi-Disciplinary Coordination And Multi-Disciplinary Study


    More Info.
    Rajeev Shrivastava
    Department of Radiation Oncology
    Aditya Birla Memorial Hospital
    India
    dr_shriraj@yahoo.co.in
    GJCT

    Research Interest: Carcinoma Lung, Breast and Cervix

    More Info.
    Francisco Torrens
    Associated Professor
    Deparmenr of Biochemistry & Molecular Biology
    Universidad de Murcia,
    Spain
    Francisco.Torrens@uv.es
    GJCT

    Research Interest: Theoretical Chemistry, Physical Chemistry, Mathematical Chemistry, Computational Chemistry, Molecular Modelling, Simulation, And Design, Computer-Aided Drug Design And Development, Molecular Graphics And Representation Of Molecular Properties.


    More Info.
    Leonard Amaral
    Professor
    Universidade Nova de Lisboa
    Portugal
    LAmaral@ihmt.unl.pt
    GJCT

    Research Interest: Bacteriology, Immunology, Hematology, Clinical Pathology, Chemical Pathology, Endocrinology, Cancer, Human Embryology, Methods For Clinical Laboratories


    More Info.
    Zhu Shu
    Yale University
    USA
    shu.zhu@yale.edu
    GJCT

    Research Interest: To Study How Our Immune Systems Recognize “Self” (The Host) Or “Non-¬‐Self” (Foreign Material) Antigens, And How The Break Of These Processes Leads To The Consequent Disease Pathology, Including Infectious Diseases And Autoimmune Diseases.


    More Info.
    Prakash Paudyal
    Department of Pharmacology
    The University of Lowa
    USA
    ppaudyal2003@yahoo.com
    GJCT

    Research Interest: Role of GPCR signaling in cancer progression and metastasis.


    More Info.
    View more
    mendeley

    Total Oncology is necessary for Japanese new era

    DOI Logo 10.17352/2581-5407.000022 CrossMark

    Published On: October 13, 2018 | Pages: 001 - 003

    Author(s): Tsuyoshi Shirakawa*
    Abstract View Full Article View Get Citation Base Search Scilit
    mendeley

    Video Endoscopic Inguinal Lymphadenectomy: Refi ning surgical technique after ten years experience

    DOI Logo 10.17352/gjct.000021 CrossMark

    Published On: December 30, 2017 | Pages: 034 - 037

    Author(s): Marcos Tobias-Machado, Pericles Rios Auad*, Victor Corona, Igor Silva, Oseas de Castro Neves, Eliney Ferreira Faria, Pablo Matos, Alexandre Cesar Santos, Roberto Machado, Aurus Dourado and Hamilton de Campos Zampolli
    Abstract View Full Article View Get Citation Base Search Scilit
    mendeley

    Role of tumor heterogeneity in drug resistance

    DOI Logo 10.17352/gjct.000020 CrossMark

    Published On: July 20, 2017 | Pages: 032 - 033

    Author(s): Dhruv Kumar*
    Abstract View Full Article View Get Citation Base Search Scilit
    mendeley

    MEK Inhibitors in Combination with Immune Checkpoint Inhibition: Should we be Chasing Colorectal Cancer or the KRAS Mutant Cancer

    DOI Logo 10.17352/gjct.000019 CrossMark

    Published On: May 26, 2017 | Pages: 030 - 031

    Author(s): Julius Strauss*
    Abstract View Full Article View Get Citation Base Search Scilit
    mendeley

    Angiosarcoma of the Scalp and Face: A Hard to Treat Tumor

    DOI Logo 10.17352/gjct.000018 CrossMark

    Published On: April 15, 2017 | Pages: 026 - 029

    Author(s): Jmour Omar*, Kochbati Lotfi , Ghith Sahar and Benna Farouk
    Abstract View Full Article View Get Citation Base Search Scilit
    mendeley

    The Promise of Disease Management in Greece

    DOI Logo 10.17352/gjct.000017 CrossMark

    Published On: March 30, 2017 | Pages: 018 - 025

    Author(s): Konstantinos Stamatiou, Richard Lacroix, Eleni Almpani, Konstantinos Katsanos, Georgios Tzitzikos and Maria Saridi*
    Abstract View Full Article View Get Citation Base Search Scilit
    mendeley

    Abrikossoff’s Tumour Mimicking a Neoplastic Tumour of the Breast: A Case Report

    DOI Logo 10.17352/gjct.000016 CrossMark

    Published On: March 20, 2017 | Pages: 015 - 017

    Author(s): Alassiri A*, Al Ali A, Vaysse C, Escourrou G, Vinet B and Rimailho J
    Abstract View Full Article View Get Citation Base Search Scilit
    mendeley

    The Role of Decavanadate in Anti- Tumour Activity

    DOI Logo 10.17352/gjct.000015 CrossMark

    Published On: March 11, 2017 | Pages: 012 - 014

    Author(s): M Aureliano*
    Abstract View Full Article View Get Citation Base Search Scilit
    mendeley

    Diagnosing HPV-Related Oropharyngeal Cancers: The Need to Speak a Common Language

    DOI Logo 10.17352/gjct.000014 CrossMark

    Published On: March 07, 2017 | Pages: 008 - 011

    Author(s): Daniela Russo#, Francesco Merolla#, Gennaro Ilardi*, Silvia Varricchio, Danila Caroppo, Virginia Napolitano, Massimo Mascolo and Stefania Staibano
    Abstract View Full Article View Get Citation Base Search Scilit
    mendeley

    Is it Time for the Introduction of Colostomy Free Survival in Rectal Cancer Patients

    DOI Logo 10.17352/gjct.000013 CrossMark

    Published On: February 28, 2017 | Pages: 004 - 007

    Author(s): Mostafa El Haddad*
    Abstract View Full Article View Get Citation Base Search Scilit

     

    Clients' voices

    Readmore

    Global Views

    Case Reports

    Peertechz Tweets

    Pinterest on GJCT